Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Apr;65(4):509–514. doi: 10.1038/bjc.1992.105

Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction.

M Katayama 1, K Kamihagi 1, S Hirai 1, T Kurome 1, K Murakami 1, F Hino 1, I Kato 1
PMCID: PMC1977554  PMID: 1562459

Abstract

The presence of soluble laminin fragments in urine of healthy subjects, patients with diabetes, and patients with tumours was studied using sandwich immunoenzymometric assay technique. The form of urinary laminin (ULN) fragments was dramatically different from that of intact laminin, so ULN could be detected only by using monoclonal antibodies. Mean levels of ULN in lung tumour were significantly higher (171 micrograms gram-1 creatinine) than those in healthy subjects, patients, with diabetes, patients with stomach tumour, and patients with colon tumour (respectively 91, 92, 77 and 53 micrograms gram-1 creatinine). Immunopurified ULN fragments showed an apparent molecular mass of 42 KD on electrophoresis. This fragment was recognised as being derived from the N-terminal region of laminin B2 chain, because the N-terminal residues of ULN were found to be completely homologous to B2 chain. These data suggested that ULN was almost all fragmented, consisted mainly of N-terminal domain of the B2 chain, and was suspected of a tumour-associated protein fragments probably derived from basement membrane degraded proteolytically by tumour cells. ULN, increased in tumour patients, could be a potential clinical marker for monitoring the turnover of basement membrane in tumours.

Full text

PDF
514

Images in this article

511Figure 1
on p.511
512Figure 5
on p.512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albini A., Aukerman S. L., Ogle R. C., Noonan D. M., Fridman R., Martin G. R., Fidler I. J. The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants. Clin Exp Metastasis. 1989 Jul-Aug;7(4):437–451. doi: 10.1007/BF01753664. [DOI] [PubMed] [Google Scholar]
  2. Albrechtsen R., Nielsen M., Wewer U., Engvall E., Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res. 1981 Dec;41(12 Pt 1):5076–5081. [PubMed] [Google Scholar]
  3. Beck K., Hunter I., Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J. 1990 Feb 1;4(2):148–160. doi: 10.1096/fasebj.4.2.2404817. [DOI] [PubMed] [Google Scholar]
  4. Boyd D., Ziober B., Chakrabarty S., Brattain M. Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma. Cancer Res. 1989 Feb 15;49(4):816–820. [PubMed] [Google Scholar]
  5. Brocks D. G., Strecker H., Neubauer H. P., Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem. 1986 May;32(5):787–791. [PubMed] [Google Scholar]
  6. Hynes R. O., Yamada K. M. Fibronectins: multifunctional modular glycoproteins. J Cell Biol. 1982 Nov;95(2 Pt 1):369–377. doi: 10.1083/jcb.95.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jones P. A., De Clerck Y. A. Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev. 1982;1(4):289–317. doi: 10.1007/BF00124214. [DOI] [PubMed] [Google Scholar]
  8. Jukkola A., Risteli J., Autio-Harmainen H., Risteli L. Effects of experimental nephrosis on basement-membrane components and enzymes of collagen biosynthesis in rat kidney. Biochem J. 1985 Feb 15;226(1):243–250. doi: 10.1042/bj2260243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kardana A., Taylor M. E., Southall P. J., Boxer G. M., Rowan A. J., Bagshawe K. D. Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues. Br J Cancer. 1988 Sep;58(3):281–286. doi: 10.1038/bjc.1988.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Katayama M., Hino F., Kamihagi K., Sekiguchi K., Titani K., Kato I. Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies. Clin Chem. 1991 Mar;37(3):466–471. [PubMed] [Google Scholar]
  11. Kleinman H. K., Cannon F. B., Laurie G. W., Hassell J. R., Aumailley M., Terranova V. P., Martin G. R., DuBois-Dalcq M. Biological activities of laminin. J Cell Biochem. 1985;27(4):317–325. doi: 10.1002/jcb.240270402. [DOI] [PubMed] [Google Scholar]
  12. Kropf J., Gressner A. M., Negwer A. Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem. 1988 Oct;34(10):2026–2030. [PubMed] [Google Scholar]
  13. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987 Jul 25;262(21):10035–10038. [PubMed] [Google Scholar]
  14. Mattila A. L., Saario I., Viinikka L., Ylikorkala O., Perheentupa J. Urinary epidermal growth factor concentrations in various human malignancies. Br J Cancer. 1988 Feb;57(2):139–141. doi: 10.1038/bjc.1988.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pikkarainen T., Kallunki T., Tryggvason K. Human laminin B2 chain. Comparison of the complete amino acid sequence with the B1 chain reveals variability in sequence homology between different structural domains. J Biol Chem. 1988 May 15;263(14):6751–6758. [PubMed] [Google Scholar]
  16. Ramos D. M., Berston E. D., Kramer R. H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res. 1990 Feb 1;50(3):728–734. [PubMed] [Google Scholar]
  17. Risteli J., Draeger K. E., Regitz G., Neubauer H. P. Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia. 1982 Sep;23(3):266–269. doi: 10.1007/BF00252853. [DOI] [PubMed] [Google Scholar]
  18. Rohde H., Bächinger H. P., Timpl R. Characterization of pepsin fragments of laminin in a tumor basement membrane. Evidence for the existence of related proteins. Hoppe Seylers Z Physiol Chem. 1980 Nov;361(11):1651–1660. doi: 10.1515/bchm2.1980.361.2.1651. [DOI] [PubMed] [Google Scholar]
  19. Teale D. M., Khidair I. A., Potter C. W., Rees R. C. Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts. Br J Cancer. 1988 May;57(5):475–480. doi: 10.1038/bjc.1988.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Terranova V. P., Liotta L. A., Russo R. G., Martin G. R. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res. 1982 Jun;42(6):2265–2269. [PubMed] [Google Scholar]
  21. Timpl R., Rohde H., Risteli L., Ott U., Robey P. G., Martin G. R. Laminin. Methods Enzymol. 1982;82(Pt A):831–838. doi: 10.1016/0076-6879(82)82104-6. [DOI] [PubMed] [Google Scholar]
  22. Timpl R., Rohde H., Robey P. G., Rennard S. I., Foidart J. M., Martin G. R. Laminin--a glycoprotein from basement membranes. J Biol Chem. 1979 Oct 10;254(19):9933–9937. [PubMed] [Google Scholar]
  23. Wewer U., Albrechtsen R., Manthorpe M., Varon S., Engvall E., Ruoslahti E. Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis. J Biol Chem. 1983 Oct 25;258(20):12654–12660. [PubMed] [Google Scholar]
  24. Würz H., Crombach G. Radioimmunoassay of laminin P1 in body fluids of pregnant women, patients with gynaecological cancer and controls. Tumour Biol. 1988;9(1):37–46. doi: 10.1159/000217543. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES